Alexandria Real Estate Equities, Inc.

NYQ: ARE
Live Quote

📈 ZcoreAI Score

Our AI model analyzes Alexandria Real Estate Equities, Inc.'s price action across multiple timeframes using regression channels and statistical scoring.

Get ARE Z-Score →

About Alexandria Real Estate Equities, Inc.

Real Estate REIT - Office
Alexandria Real Estate Equities, Inc. an S&P 500 company, is a best-in-class, mission-driven life science REIT making a positive and lasting impact on the world. With our founding in 1994, Alexandria pioneered the life science real estate niche. Alexandria is the preeminent and longest-tenured owner, operator, and developer of collaborative Mega campus ecosystems in AAA life science innovation cluster locations, including Greater Boston, the San Francisco Bay Area, San Diego, Seattle, Maryland, Research Triangle, and New York City. As of December 31, 2025, Alexandria has a total market capitalization of 20.75 billion US dollars and an asset base in North America that includes 35.9 million RSF of operating properties and 3.5 million RSF of Class A/A+ properties undergoing construction. Alexandria has a long-standing and proven track record of developing Class A/A+ properties clustered in highly dynamic and collaborative Mega campus environments that enhance our tenant ability to successfully recruit and retain world-class talent and inspire productivity, efficiency, creativity, and success. Alexandria also provides strategic capital to transformative life science companies through our venture capital platform. We believe our unique business model and diligent underwriting ensure a high-quality and diverse tenant base that results in higher occupancy levels, longer lease terms, higher rental income, higher returns, and greater long-term asset value. Alexandria Real Estate Equities, Inc. was incorporated in 1996 in Maryland, USA.

📊 Fundamental Analysis

Alexandria Real Estate Equities, Inc. demonstrates a profit margin of -47.4%, which is below the sector average, suggesting competitive pressure.

The company recently reported -5.2% revenue growth, which is negative, indicating a recent decline in revenue.

Return on Equity (ROE) is -5.9%, which indicates that capital utilization is currently under pressure.

At a current price of $42.61, ARE currently trades near the bottom of its 52-week range (3%), indicating potential value or weakness (Range: $41.44 - $88.24).

🏥 Financial Health

🔴 Profit Margin Weak
Debt/Equity Excellent
🔴 Revenue Growth Weak
🔴 Return on Equity Weak
🔴 Beta (Risk) High Volatility

Key Financials

Market Cap
$7.38B
Trailing P/E
--
Forward P/E
-532.62
Beta (5Y)
1.34
52W High
$88.24
52W Low
$41.44
Avg Volume
2.57M
Day High
Day Low
Get ARE Z-Score on Dashboard 🚀